Humana Inc.

NYSE:HUM Voorraadrapport

Marktkapitalisatie: US$28.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Humana Toekomstige groei

Future criteriumcontroles 1/6

Humana zal naar verwachting groeien in winst en omzet met respectievelijk 19.1% en 4.3% per jaar. De winst per aandeel zal naar verwachting groeien met 21.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 15.5% zijn.

Belangrijke informatie

15.1%

Groei van de winst

17.8%

Groei van de winst per aandeel

Healthcare winstgroei19.3%
Inkomstengroei3.4%
Toekomstig rendement op eigen vermogen14.7%
Dekking van analisten

Good

Laatst bijgewerkt04 Oct 2024

Recente toekomstige groei-updates

Recent updates

Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump

Oct 03
Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump

Wall Street Lunch: Humana Shares Hit Hard

Oct 02

Humana's Falling Share Price Gives Investors An Opportunity

Sep 18

Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Sep 15
Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Aug 19
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Jul 24

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Jul 16
Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Jun 23

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Jun 20
Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Jun 06
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Humana Is Set Up For Long-Term Success

Jun 05

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

May 21
Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Apr 22
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Apr 20
Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana: Where To Buy This

Apr 02

Humana: This Year's Drop Might Have Created A Buying Opportunity

Mar 19

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Feb 03

Humana: The $300 Level Could Get Taken Out In The Near Future

Jan 25

Humana: My Oh My, Another Strong Buy

Jan 14

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Jan 02

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Dec 14
Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Dec 11

Humana: Upgrade To Buy

Oct 06

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Sep 27

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Aug 25
We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana: Mr. Market Got This One Right

Aug 03

Humana: Recent Selloff Might Present A Buying Opportunity

Jul 13

Humana: Rising Medical Costs Should Be Temporary

Jun 28

Humana: Margin Expansion Supported By Growing Memberships

Jun 12

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

May 26
Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 13
Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Humana Q4 2022 Earnings Preview

Jan 31

Humana: Destined For A Long-Term Success

Jan 23

Humana (NYSE:HUM) Could Easily Take On More Debt

Jan 13
Humana (NYSE:HUM) Could Easily Take On More Debt

Humana receives $70.85B contract from Defense Health Agency

Dec 22

Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Dec 20
Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Humana: Top-Rated Medicare Advantage Insurer With Room To Grow

Nov 14

Humana prices $1.23B debt offering

Nov 08

Winst- en omzetgroeiprognoses

NYSE:HUM - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026121,0232,5223,3564,38614
12/31/2025115,7112,2232,5523,20816
12/31/2024116,2741,7022,5422,43515
6/30/2024112,0361,711-5,054-4,246N/A
3/31/2024109,2431,991-3,241-2,283N/A
12/31/2023106,3742,4892,9773,981N/A
9/30/2023102,3513,0154,9925,988N/A
6/30/202398,7273,37812,13913,189N/A
3/31/202395,6423,1159,90710,972N/A
12/31/202292,8702,8063,4504,587N/A
9/30/202291,4852,8078,3859,618N/A
6/30/202290,5123,1432,7294,000N/A
3/31/202287,4953,0352,0803,401N/A
12/31/202183,0642,9339202,262N/A
9/30/202182,2012,6731,4002,641N/A
6/30/202180,4502,4824561,621N/A
3/31/202178,8883,7223,2664,328N/A
12/31/202077,1553,3674,6755,639N/A
9/30/202074,3884,1534,9705,868N/A
6/30/202070,5543,5025,6376,495N/A
3/31/202067,7162,6144,0734,862N/A
12/31/201964,8882,7074,5485,284N/A
9/30/201962,7612,5503,7574,439N/A
6/30/201960,7262,505306942N/A
3/31/201958,7401,758-1,234-617N/A
12/31/201856,9121,6831,5612,173N/A
9/30/201855,9331,512-989-405N/A
6/30/201855,0091,3672,9503,513N/A
3/31/201854,2841,824N/A3,532N/A
12/31/201753,7672,448N/A4,051N/A
9/30/201753,4561,863N/A4,189N/A
6/30/201753,8681,814N/A5,829N/A
3/31/201754,3411,475N/A5,639N/A
12/31/201654,379614N/A1,936N/A
9/30/201654,8621,116N/A5,046N/A
6/30/201654,531980N/A1,575N/A
3/31/201654,2561,100N/A1,263N/A
12/31/201554,2891,276N/A868N/A
9/30/201553,2561,320N/A724N/A
6/30/201552,1311,296N/A646N/A
3/31/201550,6211,209N/A1,054N/A
12/31/201448,5001,147N/A1,618N/A
9/30/201446,359972N/A1,409N/A
6/30/201444,4401,050N/A1,602N/A
3/31/201442,5391,126N/A1,975N/A
12/31/201341,3131,231N/A1,716N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei HUM ( 19.1% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van HUM ( 15.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.1% per jaar).

Hoge groeiwinsten: De winst van HUM zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van HUM ( 4.3% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van HUM ( 4.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen HUM zal naar verwachting over 3 jaar laag zijn ( 15.5 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y